The study on ESG in pharmaceuticals reveals gaps in social criteria compliance despite increasing regulatory pressures. Roland Berger categorized companies into three maturity levels—initiators, aspirers, and frontrunners—and identified key areas for improvement, such as access to medicines. The findings stress the need for broader engagement in social issues to enhance overall ESG performance.
This new Roland Berger publication explores the potential – and the problems – in bringing proven artificial intelligence (AI) together with emerging quantum technologies. Far from blue-sky thinking, many companies already have this massively lucrative prize firmly in their sights.
How IT executives can respond to key trends in IT – and how companies can get ready for AI IT study 2024 – Trends, challenges and implications.
Die Experten von Roland Berger haben an der CES 2025 in Las Vegas die neuesten technologischen Trends und Innovationen erkundet, die unsere Zukunft gestalten. In unserem Webinar "Summing up CES 2025", erhalten Sie spannende Einblicke von unseren Partnern Falk Meissner, Konstantin Shirokinskiy, Steffen Thiel, Isaac Chan und Nikolaus Lehmann in wegweisende Entwicklungen wie KI, autonome Systeme und nachhaltige Technologien – und deren transformative Wirkung auf unsere Welt. Weitere Informationen erhalten Sie hier.
, Westeuropa
